Skip to content

Prostate surgery on blood thinners or with a catheter

What each technique allows for men on blood thinners and what the studies show for men who depend on a catheter.

Dr. Petronio Melo, urologistA reference in enlarged prostate (BPH) treatment
CRM-SP 157.598 · RQE 70.275
Reviewed by Dr. Petronio Melo on November 18, 2026
Book a consultation
Drawing of the bladder with a thick wall and the enlarged prostate seen from the front, with a catheter running through the urethra and the balloon above the bladder neck. Beside it, a blood vessel opened lengthwise, with red blood cells flowing freely
On this page

Quick answer

Men who take anticoagulants or antiplatelet drugs can have surgery for an enlarged prostate, and so can men who depend on a catheter. What changes is the technique. In my practice, I perform Greenlight on men who take anticoagulants without stopping the medication. For HoLEP, I stop it when possible and, if not, I operate anyway. For TURP, I stop it whenever possible, and for robotic simple prostatectomy, always. For Rezum and EchoLaser, the decision is case by case. In every case, it is made together with the doctor who prescribed the medication. Most men with a catheter because of urinary retention urinate without it afterwards, with any of the techniques studied.12,13,15,17

Anticoagulants and antiplatelet drugs

These are medications that thin the blood and protect the heart and brain from clots. Antiplatelet drugs, such as aspirin and clopidogrel, act on platelets. Anticoagulants act on clotting: warfarin is the oldest, and the newer ones include rivaroxaban, apixaban and dabigatran.

In prostate surgery, these medications make it harder to control bleeding, during and after the operation. On the other hand, stopping them without a plan can cause serious complications in men who had a recent clot, have a mechanical valve, atrial fibrillation or a heart stent.2 So never stop, reduce or switch the medication on your own.

What each technique allows

This is my practice with anticoagulants for each technique. In every case, the decision is made together with the doctor who prescribed the medication.

TechniqueIn my practice
GreenlightI operate without stopping the anticoagulant
HoLEPI stop it when possible; if not, I operate with the medication
TURPI stop it whenever possible; heparin bridging is decided case by case by the doctor who manages the medication, and aspirin case by case
RezumCase by case, together with the doctor who prescribed the medication
EchoLaserCase by case, together with the doctor who prescribed the medication
Robotic simpleI always stop it; when it cannot be stopped, I consider another type of surgery

The details for each one are on the pages for Greenlight, HoLEP, TURP, Rezum and EchoLaser for men on blood thinners or with a catheter.

What the studies show about bleeding

In a 2026 review of 15 studies with 6,091 men, those who continued anticoagulants or antiplatelet drugs during surgery had more bleeding complications after TURP and after enucleation. After Greenlight, transfusion and surgery to stop bleeding occurred at rates similar to those of men not taking these drugs, and the authors suggest vaporization for men who need to keep the medication without a break.3

TechniqueStudyResult
HoLEP and TURPGermany, 2021: 221 men continuing the medication, in matched pairsHemoglobin drop of 0.7 with HoLEP and 2.2 with TURP; adverse events in 5.4% and 16.4%4
TURPSwitzerland, 2019: bipolar TURP without stopping the medicationAspirin with no difference; with clopidogrel, transfusion in 19%, versus 1%5
RezumJapan, 2026: two studies of men who kept taking the medicationMore blood in the urine, with no transfusion and no repeat surgery6,7
EchoLaserExpert consensus, 202496% considered the treatment safe in men on anticoagulants or antiplatelet drugs9

For Rezum, there is still no formal recommendation from urological societies on how to manage anticoagulants.8 Men who cannot stop the medication have other options. In my practice, HoLEP is possible even in men who take anticoagulants, and Greenlight is done without stopping the medication.

What the guidelines say

European Association of Urology. For men on anticoagulants or antiplatelet drugs, the guideline recommends offering laser vaporization, such as Greenlight, for prostates smaller than 80 g, and thulium laser enucleation, both with a weak recommendation. It also describes HoLEP as performed safely in this group, although randomized studies are still lacking.1 In practice, prostate size and technique have to be assessed case by case.

American Urological Association. The review written with the International Consultation on Urological Diseases points out that stopping or switching these medications without a plan can cause serious complications in men who had a recent clot, have a mechanical valve, atrial fibrillation or a heart stent. It advises postponing surgery that can wait when it would require stopping both antiplatelet drugs in someone who recently had a stent placed, and restarting the medication as soon as the bleeding risk drops.2

How long to pause, and bridging. In a study of 3,007 people with atrial fibrillation, the newer anticoagulants were stopped a few days before surgery, according to the drug, the bleeding risk and kidney function, without heparin injections, and major bleeding and arterial clots stayed at low rates.10 In a study of 1,884 people with atrial fibrillation who stopped warfarin, going without heparin bridging protected just as well against stroke and other arterial clots and caused less major bleeding, 1.3% versus 3.2%.11 That is why bridging is decided case by case, by the doctor who manages the medication.

If you depend on a catheter

Urinary retention is when the bladder cannot empty. It can be acute, when urine stops suddenly, or chronic, when the bladder fills up little by little. These are the catheter removal figures the studies show for each technique:

TechniqueStudyCatheter-free afterwards
GreenlightCanada, 2024: 88 men in retention83% at the first attempt and 87.5% at 1 year12
HoLEPCanada, 2024: 189 men in retention; United States, 2005: 164 men96.3% at 12 months; in the American study, all13,14
TURPLondon, 1999: 379 men; United Kingdom, 2023: 147 men aged 80 or olderOnly 1% needed a long-term catheter; in the older men, 79.6% catheter-free at 1 year15,16
RezumReview of 24 studies of men who depended on a catheter68% to 100%, depending on the study17
EchoLaserFlorence, 2024: 14 men who had a catheter9 of 1419

In men who already depended on a catheter, it can take longer to come out after Rezum and EchoLaser. In a Canadian Rezum study, 49% could not urinate at the first attempt, at 14 days, and 79% became catheter-free later.18 For EchoLaser, an expert consensus recommended keeping the catheter for 7 to 15 days after treatment in men who already had one, and removal usually happens between 7 days and 1 month.9

How I approach it

Before recommending surgery, I look at which medications you take, why you take them and how long you have had a catheter, and I assess the bladder. Then I compare the techniques with you and, when there is an anticoagulant, I agree on the plan with the doctor who prescribed it.

I have performed Greenlight since 2019, with more than 500 operations, and I operate on men who take anticoagulants without stopping the medication. I am a proctor of Greenlight and Rezum. I have performed en bloc HoLEP since 2022, EchoLaser since 2025, TURP since 2015 and robotic simple prostatectomy since 2020. Between Greenlight and TURP, both are good options, but I have been prioritizing Greenlight for its safety profile and lower risk of bleeding. What to expect after each technique is in recovery after each operation.

When to see a urologist

  • If you take anticoagulants or antiplatelet drugs and need prostate surgery
  • If you were told you would have to stop the medication to have surgery
  • If you have a catheter because of your prostate
  • After surgery, if the urine has clots or stops coming out

Send your case

If you take blood thinners or have a catheter and would like my opinion, before a consultation, on which technique makes sense for your case, fill in the form below. Tell me which medications you take and how long you have had the catheter. It goes to my office, and you will get a reply within 24 hours by email or WhatsApp. The form does not replace a consultation: it helps plan the next step.

Frequently asked questions

Can men who take anticoagulants have surgery for an enlarged prostate?

Yes. The European guideline recommends offering laser vaporization, such as Greenlight, or thulium laser enucleation to men on anticoagulants or antiplatelet drugs, both with a weak recommendation, and describes HoLEP as performed safely in this group.1 In my practice, I perform Greenlight on men who take anticoagulants without stopping the medication, and HoLEP is possible even with the medication when it cannot be stopped.

Do I need to stop my anticoagulant before prostate surgery?

It depends on the technique and on why you take it. In my practice, I do not stop it for Greenlight. For HoLEP, I stop it when possible. For TURP, I stop it whenever possible, and for robotic simple prostatectomy, always. For Rezum and EchoLaser, the decision is case by case. In every case, it is made together with the doctor who prescribed the medication, because stopping without a plan can bring a risk of thrombosis.2 Never stop the medication on your own.

Which operation bleeds less in men who cannot stop their anticoagulant?

In a review of 15 studies with 6,091 men, continuing anticoagulants or antiplatelet drugs increased bleeding after TURP and after enucleation, but not after Greenlight.3 In a study of matched pairs of men, all continuing the medication, HoLEP bled less than TURP.4

Will I need heparin injections in place of my anticoagulant?

Not always, and the decision belongs to the doctor who manages the medication. In a study of 1,884 people with atrial fibrillation who stopped warfarin, going without the injections protected just as well against stroke and other arterial clots and caused less major bleeding, 1.3% versus 3.2%.11

Can men who depend on a catheter have prostate surgery?

Yes, and most of them urinate without it afterwards. After Greenlight, 87.5% were catheter-free at 1 year in a Canadian study.12 After HoLEP, 96.3% were catheter-free at 12 months.13 After TURP, only 1% of 379 men needed a long-term catheter.15 After Rezum, the catheter came out in 68% to 100% of cases, depending on the study.17

What if my bladder is weak?

Surgery can still help, but improvement tends to be smaller. In a review of 10 studies, men with a weak bladder on urodynamic testing improved less in symptoms and flow.20 After HoLEP, satisfaction was 90.5% with a weak bladder and 95.2% without one.21 That is why I assess the bladder before recommending surgery.

Does aspirin also need to be stopped?

It depends. In a Swiss study of bipolar TURP, men who continued aspirin had results similar to those of men who did not take these drugs, and with clopidogrel the transfusion rate was 19%, versus 1%.5 In my practice, I assess aspirin case by case, like every medication, always together with the doctor who prescribed it.

Who operates on the prostate in São Paulo for men on blood thinners or with a catheter?

I am Dr. Petronio Melo, urologist and robotic surgeon in São Paulo, CRM-SP 157.598 and RQE 70.275. I have performed Greenlight since 2019, with more than 500 operations, and I operate on men who take anticoagulants without stopping the medication. I was one of the pioneers of Rezum in Brazil and I am a proctor of Greenlight and Rezum. I have performed en bloc HoLEP since 2022, EchoLaser since 2025, TURP since 2015 and robotic simple prostatectomy since 2020. My office is in Vila Mariana, and the first consultation can be in person or online, in English.

References

  1. EAU Guidelines on the Management of Non-neurogenic Male LUTS. European Association of Urology; 2026. Disease management chapter. EAU
  2. Culkin DJ, Exaire EJ, Green D, et al. Anticoagulation and antiplatelet therapy in urological practice: ICUD/AUA review paper. J Urol. 2014;192(4):1026-34. PubMed
  3. Giulioni C, Cafarelli A, Falsetti F, et al. Perioperative outcomes of ongoing antithrombotic therapy during endoscopic surgery for benign prostatic hyperplasia: a systematic review and meta-analysis of observational studies. Prostate Cancer Prostatic Dis. 2026;29(4):735-753. PubMed
  4. Westhofen T, Schott M, Keller P, et al. Superiority of holmium laser enucleation of the prostate over transurethral resection of the prostate in a matched-pair analysis of bleeding complications under various antithrombotic regimens. J Endourol. 2021;35(3):328-34. PubMed
  5. Rühle A, Blarer J, Oehme F, et al. Safety and effectiveness of bipolar transurethral resection of the prostate in patients under ongoing oral anticoagulation with coumarins or antiplatelet drug therapy compared to patients without anticoagulation/antiplatelet therapy. J Endourol. 2019;33(6):455-462. PubMed
  6. Fujisawa N, Washino S, Yasuda Y, et al. Safety and Efficacy of Rezūm Water Vapor Energy Therapy for Benign Prostatic Hyperplasia With Continued Antithrombotic Therapy: A Comparative Study. Low Urin Tract Symptoms. 2026;18(5):e70094. PubMed
  7. Moriwake T, Tominaga Y, Katayama S, et al. Safety and efficacy of Rezūm water vapour energy therapy in BPH patients receiving antithrombotic therapy: A Japanese single-centre experience. BJUI Compass. 2026;7(2):e70170. PubMed
  8. Coscarella M, Secco S, Elterman DS, et al. Management of NOACs in patients undergoing water vapour thermal therapy (REZUM) for benign prostatic obstruction: a comprehensive review. World J Urol. 2025;44(1):52. PubMed
  9. Cocci A, Pezzoli M, Bianco F, et al. Transperineal laser ablation of the prostate as a treatment for benign prostatic hyperplasia and prostate cancer: the results of a Delphi consensus project. Asian J Urol. 2024;11(2):271-279. PubMed
  10. Douketis JD, Spyropoulos AC, Duncan J, et al. Perioperative management of patients with atrial fibrillation receiving a direct oral anticoagulant. JAMA Intern Med. 2019;179(11):1469-1478. PubMed
  11. Douketis JD, Spyropoulos AC, Kaatz S, et al. Perioperative bridging anticoagulation in patients with atrial fibrillation. N Engl J Med. 2015;373(9):823-33. PubMed
  12. MacDonald A, Fathy M, Nikoufar P, et al. Efficacy of GreenLight laser prostatectomy in urinary retention. Can Urol Assoc J. 2024;18(4):E120-E126. PubMed
  13. Alhelal S, Nikoufar P, Hodhod A, et al. Efficacy and durability of holmium laser enucleation of the prostate in the management of acute and chronic urinary retention: a retrospective study. Can Urol Assoc J. 2024;18(10):302-9. PubMed
  14. Peterson MD, Matlaga BR, Kim SC, et al. Holmium laser enucleation of the prostate for men with urinary retention. J Urol. 2005;174(3):998-1001. PubMed
  15. Reynard JM, Shearer RJ. Failure to void after transurethral resection of the prostate and mode of presentation. Urology. 1999;53(2):336-9. PubMed
  16. Antoniou V, Edris F, Akpobire W, et al. Surgical outcomes for elderly patients undergoing transurethral resection of the prostate for chronic urinary retention and proposal of a management algorithm. J Endourol. 2023;37(5):581-586. PubMed
  17. Scilipoti P, Chicaud M, Abdallah MA, et al. Minimally Invasive Surgical Therapies in Patients with Catheter-Dependent Urinary Retention: A Collaborative Mini-review. Eur Urol Focus. 2026. PubMed
  18. Ramjiawan R, Chung D, Fidel MG, et al. Efficacy of Rezūm water vapor therapy for the treatment of catheter-dependent urinary retention: a single-center, Canadian experience. Can Urol Assoc J. 2025;19(1):E18-E24. PubMed
  19. Lo Re M, Polverino P, Rivetti A, et al. Transperineal laser ablation (TPLA) of the prostate for benign prostatic obstruction: the first 100 patients cohort of a prospective, single-center study. World J Urol. 2024;42(1):402. PubMed
  20. Kim M, Jeong CW, Oh SJ. Effect of preoperative urodynamic detrusor underactivity on transurethral surgery for benign prostatic hyperplasia: a systematic review and meta-analysis. J Urol. 2018;199(1):237-244. PubMed
  21. Jeong HJ, Lee H, Choo MS, et al. Effect of detrusor underactivity on surgical outcomes of holmium laser enucleation of the prostate. BJU Int. 2024;133(6):770-7. PubMed

Would you like to talk about your case?

In the consultation, I go over your tests and your priorities.

Book a consultation5.0186 Google reviews

Related guides